101 related articles for article (PubMed ID: 16874156)
1. Using structural equation model to illustrate the relationship between metabolic risk factors and cardiovascular complications in Taiwan.
Lin JW; Hwang JJ; Dai DF; Tseng YZ
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):633-9. PubMed ID: 16874156
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.
Najarian RM; Sullivan LM; Kannel WB; Wilson PW; D'Agostino RB; Wolf PA
Arch Intern Med; 2006 Jan; 166(1):106-11. PubMed ID: 16401818
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome in type 2 diabetes: When does it matter?
Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
[TBL] [Abstract][Full Text] [Related]
4. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
Lin CC; Liu CS; Li TC; Chen CC; Li CI; Lin WY
Eur J Clin Invest; 2007 Oct; 37(10):783-90. PubMed ID: 17888089
[TBL] [Abstract][Full Text] [Related]
5. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke.
Maruyama K; Uchiyama S; Iwata M
J Stroke Cerebrovasc Dis; 2009; 18(3):173-7. PubMed ID: 19426885
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
8. Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.
Park JH; Kwon HM
Clin Neurol Neurosurg; 2008 Mar; 110(3):215-21. PubMed ID: 18055103
[TBL] [Abstract][Full Text] [Related]
9. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese.
Wang J; Li H; Franco OH; Yu Z; Liu Y; Lin X
Obesity (Silver Spring); 2008 Jan; 16(1):172-8. PubMed ID: 18223631
[TBL] [Abstract][Full Text] [Related]
11. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
[TBL] [Abstract][Full Text] [Related]
12. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
Cheung BM; Wat NM; Man YB; Tam S; Cheng CH; Leung GM; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
Am J Hypertens; 2008 Jan; 21(1):17-22. PubMed ID: 18091739
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
[TBL] [Abstract][Full Text] [Related]
15. Association between abnormal liver function and risk factors for metabolic syndrome among freshmen.
Tsai PY; Yen CJ; Li YC; Chiu TY; Chen CY; Jan CF
J Adolesc Health; 2007 Aug; 41(2):132-7. PubMed ID: 17659216
[TBL] [Abstract][Full Text] [Related]
16. Metabolic risk factors associated with erosive esophagitis.
Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
[TBL] [Abstract][Full Text] [Related]
17. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
18. Association of cardiometabolic risk factors and prevalent cardiovascular events.
Malone DC; Boudreau DM; Nichols GA; Raebel MA; Fishman PA; Feldstein AC; Ben-Joseph RH; Okamoto LJ; Boscoe AN; Magid DJ
Metab Syndr Relat Disord; 2009 Dec; 7(6):585-93. PubMed ID: 19900158
[TBL] [Abstract][Full Text] [Related]
19. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mellitus.
Tsai JC; Sheu SH; Chiu HC; Chung FM; Chang DM; Chen MP; Shin SJ; Lee YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):111-8. PubMed ID: 16703635
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]